机译:杂合子患者达到LDL胆固醇水平:a?模型探讨常规和新型降脂治疗的疗效
Department of Vascular Medicine Academic Medical Centre University of Amsterdam;
Department of Vascular Medicine Academic Medical Centre University of Amsterdam;
Department of Vascular Medicine Academic Medical Centre University of Amsterdam;
Landelijk Expertisecentrum Familiaire Hypercholesterolemie (LEEFH);
Department of Internal Medicine Radboud University Medical Center;
Department of Internal Medicine Radboud University Medical Center;
Department of Vascular Medicine University Medical Center Utrecht;
Department of Internal Medicine Elisabeth-TweeSteden Ziekenhuis;
Department of Internal Medicine Erasmus Medical Center;
Department of Vascular Medicine Academic Medical Centre University of Amsterdam;
Department of Vascular Medicine Academic Medical Centre University of Amsterdam;
Department of Vascular Medicine Academic Medical Centre University of Amsterdam;
CETP inhibitor; Familial hypercholesterolemia; LDL-Cholesterol; PCSK9 inhibitor; Statin therapy;
机译:杂合子患者达到LDL胆固醇水平:a?模型探讨常规和新型降脂治疗的疗效
机译:非PCSK9i降脂治疗后低密度脂蛋白胆固醇的结果在动脉粥样硬化性心血管疾病和可能的杂合性家族性高胆固醇血症患者中的应用
机译:Alirocumab对目前尚无降脂治疗不能充分控制的杂合性家族性高胆固醇血症患者的疗效和安全性:ODYSSEY FH研究的设计和原理
机译:SCD40L的血浆水平与家族性高胆固醇血症(FH)临床诊断患者的HDL-胆固醇和APOA-1相关。
机译:高胆固醇血症患者降脂治疗生活质量量表的研制和心理计量学分析。
机译:在非PCSK9i降脂治疗后的低密度脂蛋白胆固醇结局在动脉粥样硬化性心血管疾病和可能的杂合性家族性高胆固醇血症患者中
机译:低密度脂蛋白胆固醇结果后非PCSK9I脂质降低治疗动脉粥样硬化性心血管疾病和可能的杂合族家族性高胆固醇血症患者
机译:吉非罗齐和洛伐他汀治疗高LDL和低HDL胆固醇水平的比较